HOME >> MEDICINE >> NEWS
Future therapies for stroke may block cell death

A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University.

During and after a stroke, certain cellular events take place that lead to the death of brain cells. Compounds that inhibit a group of enzymes called histone deacetylases can modulate gene expression, and in some cases produce cellular proteins that are actually neuroprotective -- they are able to block cell death.

"For the first time, we show which one of the 11 histone deacetylase enzymes might be the best target to achieve cellular neuroprotection," said the study's lead investigator, Alan Kozikowski, professor of medicinal chemistry and pharmacognosy and director of the drug discovery program at UIC. "This work gives us a good direction to follow in testing histone deacetylase inhibitors in animal models for diseases such as Parkinson's and Huntington's disease, and even stroke."

Stroke can cause permanent neurological damage or even death if not promptly diagnosed and treated. It is the third-leading cause of death and the leading cause of adult disability in the United States.

A great deal of research has gone into developing histone deacetylase inhibitors as novel therapeutics, but the majority of the work has been directed toward cancer, Kozikowski said -- in which case, paradoxically, the compounds are employed to stimulate the death of rapidly multiplying cells. The molecule known as SAHA recently received approval by the Food and Drug Administration for use in cancer therapy and is the first of the histone deacetylase inhibitors to be marketed.

"The use of histone deacetylase inhibitors in medicine would thus appear to hold tremendous promise," Kozikowski said. But to be clinically useful, he said, drugs must be designed that are able to discriminate between various forms of histone deacetylase. '"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
13-Jun-2007


Page: 1 2

Related medicine news :

1. Colon cancer screening -- Going Back To The Future?
2. CHPA president and leading physician available to comment on NIDA Monitoring the Future
3. CHPA statement regarding Monitoring the Future findings on cough medicine abuse
4. Future of nanotechnology discussed by experts
5. Future of cancer research in Europe under threat
6. Future of pain therapies at forefront of physician meeting
7. New TB test scoops top prize at Medical Futures competition
8. Mayo Clinic creates Office of the Future
9. Rice, NC State win NAS/Keck Futures funding
10. Antifolate therapies found effective against certain type of malaria
11. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... ... "Pacifica Experience" Open House day on Pacifica's Lambert Campus, 249 Lambert Road, ... Depth Psychology, the Humanities, Clinical Psychology, Counseling Psychology, and Mythological Studies. Program ...
(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... ... , ... A September 2 article on CBS News details a ... likely to suffer heart attacks, strokes, kidney failure, and heart disease versus a control ... surgery specialists Dr. Feiz and Associates says the study adds further evidence to an ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... will exhibit at the 2019 AHIMA Health Data and Information Conference in Chicago, ... stop by booth #505 to learn more about GRM’s healthcare information management ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... challenges facing specialty healthcare, announces the issuance of a patent to reduce the ... payment plan for both time-of-service and post visit patient statements. , At the ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... (PRWEB) , ... September 14, 2019 , ... ... of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County found ... consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J talc ...
(Date:9/12/2019)... CITY (PRWEB) , ... September 12, 2019 , ... ... are collaborating to help make the services of CPESN’s clinically integrated network of ... and payers. CPESN USA’s participating pharmacies provide high quality clinical service programs ...
(Date:9/11/2019)... FALLS CHURCH, Va. (PRWEB) , ... September 11, ... ... explosion is revolutionizing image analysis, with many companies developing technologies to evaluate medical ... segments. , Unless one understands the approaches the FDA is taking to AI-based ...
Breaking Medicine Technology:
Cached News: